Background: Bariatric surgery can influence the presentation, diagnosis, and management of gastrointestinal cancers. Esophagogastric (EG) malignancies in patients who have had a prior bariatric procedure have not been fully characterized. Objective: To characterize EG malignancies after bariatric procedures. Setting: University Hospital, United Kingdom. Methods: We performed a retrospective, multicenter observational study of patients with EG malignancies after bariatric surgery to characterize this condition. Results: This study includes 170 patients from 75 centers in 25 countries who underwent bariatric procedures between 1985 and 2020. At the time of the bariatric procedure, the mean age was 50.2 ± 10 years, and the mean weight 128.8 ± 28.9 kg. Women composed 57.3% (n = 98) of the population. Most (n = 64) patients underwent a Roux-en-Y gastric bypass (RYGB) followed by adjustable gastric band (AGB; n = 46) and sleeve gastrectomy (SG; n = 43). Time to cancer diagnosis after bariatric surgery was 9.5 ± 7.4 years, and mean weight at diagnosis was 87.4 ± 21.9 kg. The time lag was 5.9 ± 4.1 years after SG compared to 9.4 ± 7.1 years after RYGB and 10.5 ± 5.7 years after AGB. One third of patients presented with metastatic disease. The majority of tumors were adenocarcinoma (82.9%). Approximately 1 in 5 patients underwent palliative treatment from the outset. Time from diagnosis to mortality was under 1 year for most patients who died over the intervening period. Conclusion: The Oesophago-Gastric Malignancies After Obesity/Bariatric Surgery study presents the largest series to date of patients developing EG malignancies after bariatric surgery and attempts to characterize this condition.

Original languageEnglish
Pages (from-to)464-472
Number of pages9
JournalSurgery for Obesity and Related Diseases
Issue number4
StatePublished - Apr 2022

Bibliographical note

Publisher Copyright:
© 2021 American Society for Bariatric Surgery


A. Dayyeh has served as a speaker for Johnson and Johnson, Endogastric Solutions, and Olympus. He is a consultant to Medtronics. R. Zakeri is funded by a Royal College of Surgeons of England Research Fellowship. The other authors report no conflicts of interest.

FundersFunder number
Royal College of Surgeons of England


    • Bariatric surgery
    • Esophageal cancer
    • Esophagogastric cancer
    • Gastric cancer
    • Metabolic surgery


    Dive into the research topics of 'Esophageal and gastric malignancies after bariatric surgery: a retrospective global study'. Together they form a unique fingerprint.

    Cite this